ContributorsPublishersAdvertisers

Chemotherapy-Free Options Expand the Scope of Treatment in Leukemia and Lymphoma

onclive.com
 2021-10-12

Across the paradigms of leukemias and lymphomas, novel therapies—such as BTK inhibitors, PI3K inhibitors, time-limited therapies, and even CAR T-cell therapies—have transformed the treatment of patients and prolonged survival without the need for chemotherapy. Across the paradigms of leukemias and lymphomas, novel therapies—such as BTK inhibitors, PI3K inhibitors, time-limited...

www.onclive.com

Comments / 0

Comments / 0